Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Precision Medicine Market Grown from 2024 to 2025?

The scale of the precision medicine market has escalated swiftly in the past few years. Its value is projected to rise from $80.15 billion in 2024 to $88.73 billion in 2025, maintaining a Compound Annual Growth Rate (CAGR) of 10.7%. Factors that contributed to this growth during the historic period include rising cases of cancer, a growing number of mental health disorders, a surge in respiratory diseases, increased funding, a rise in the elderly population, an increase in pharmaceutical research and development expenditure, and growing healthcare expenditure.

What Growth Rate Is Anticipated for the Precision Medicine Market in the Coming Years?

Significant expansion is predicted for the precision medicine market in the coming years, with an increase projected to be at $129.37 billion by 2029 and a compound annual growth rate (CAGR) of 9.9%. Several factors will likely contribute to this growth during the forecasted period, including a rising elderly population, an increase in cancer cases, the vast potential of emerging markets, new occurrences of pathogenic infections, augmented spending on research and development, and an increase in healthcare spending. The forecasted period will witness several emerging trends like adopting AI technologies to enhance competitiveness, personalizing diagnosis and treatments for immune-mediated diseases, heightening investment in research and development activities, and forming alliances and cooperations with technology and healthcare organizations to bolster their product offerings.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

Who Are the Leading Companies in the Precision Medicine Market?

Major companies operating in the precision medicine market include Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

What Are the Key Drivers of the Precision Medicine Market?

The precision medicine market is expected to grow due to the increasing incidence of cancer. Cancer is a leading cause of death globally, with one in five individuals expected to develop the disease at some point in their lifetime. Precision medicine in oncology involves examining DNA from tumors to detect genetic abnormalities or mutations that trigger the cancer. Consequently, doctors may be able to select a treatment that best addresses, or targets, the modifications in the tumor DNA. For example, the World Health Organization, a specialized agency in Switzerland for international public health, estimates that by 2050 there will be over 35 million new cancer cases, an increase of 77% from the projected 20 million cases in 2022. The escalating incidence of cancer, therefore, propels the expansion of the precision medicine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5301&type=smp

What Are the Key Market Segments in the Precision Medicine Industry?

The precision medicine market covered in this report is segmented –

1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology

2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.

3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others

Subsegments:

1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining

2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis

3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing

4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials

5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests

6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

What Are the Latest Trends in the Precision Medicine Market?

The increasing prevalence of alliances and acquisitions among precision medicine businesses is diversifying their methods toward both cancer and non-cancer related fields. With ongoing advancements in precision medicine research and development, collaborative efforts and partnerships are fundamental to the expansion and enhancement of company strategies. For example, in September 2022, GSK plc, a pharmaceutical organization based in the UK, broadened its partnership with Tempus, a precision medicine firm from the US. Their three-year collaboration is designed to enhance clinical trial design, quicken patient recruitment, and employ Tempus’ AI-powered platform to identify drug targets by using broad-ranging de-identified patient data. This cooperative endeavor builds upon their previous work and is anticipated to boost GSK’s R&D capacities, with a particular focus on oncology.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

What Are the Key Regional Markets in the Precision Medicine Industry?

North America was the largest region in the precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5301

This Report Delivers Insight On:

1. How big is the precision medicine market, and how is it changing globally?

2. Who are the major companies in the precision medicine market, and how are they performing?

3. What are the key opportunities and risks in the precision medicine market right now?

4. Which products or customer segments are growing the most in the precision medicine market?

5. What factors are helping or slowing down the growth of the precision medicine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model